Johnson & Johnson (NYSE:JNJ) is reportedly halting international sales of its Linx Reflux Management System, a device used to treat chronic acid reflux. In a letter to doctors dated September 17, the ...
Sept 23 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Tuesday it will withdraw a device to treat acid reflux disease from certain markets outside the United States, citing commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback